Skip to main content

Want a detailed portfolio tracker?

Olema Pharmaceuticals (OLMA) P/E (2020 - 2026)

Olema Pharmaceuticals (OLMA) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Olema Pharmaceuticals (OLMA) P/E is -4.78. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Olema Pharmaceuticals (OLMA)

YearP/EChange
2026-4.78-56.76%
2025-11.04+305.37%
2024-2.72-56.66%
2023-6.29+544.11%
2022-0.98-81.28%
2021-5.21-97.20%
2020-186.57N/A

Comparison Olema Pharmaceuticals (OLMA) P/E with competitors

Olema Pharmaceuticals (OLMA) P/E is -4.78.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.57%
FGENFibroGen Inc0.24-105.03%
CHRSCoherus Biosciences Inc0.85-117.77%
FBIOFortress Biotech Inc0.95-119.87%
ORMPOramed Pharmaceuticals Inc1.50-131.47%
AGENAgenus Inc3.01-163.02%
INVAInnoviva Inc3.15-166.04%
VXRTVaxart Inc3.55-174.32%
CRMDCorMedix Inc3.63-175.97%
CVACCureVac N.V.4.45-193.08%
GLPGGalapagos NV4.86-201.74%
SRPTSarepta Therapeutics Inc4.88-202.22%
ABEOAbeona Therapeutics Inc5.39-212.80%
ABUSArbutus Biopharma Corp5.60-217.16%
ZVRAZevra Therapeutics Inc5.89-223.27%
SPROSpero Therapeutics Inc6.23-230.41%
CGENCompugen Ltd6.31-232.20%
RIGLRigel Pharmaceuticals6.87-243.89%
SLXNSilexion Therapeutics Corp7.30-252.77%
OMEROmeros Corporation9.26-293.86%
AUPHAurinia Pharmaceuticals Inc9.58-300.69%
PLXProtalix BioTherapeutics Inc10.89-328.04%
ACADAcadia Pharmaceuticals Inc11.73-345.57%
TBPHTheravance Biopharma Inc12.26-356.75%
ADMAAdma Biologics Inc12.42-360.01%
HRMYHarmony Biosciences Holdings Inc13.82-389.37%
SABSSAB Biotherapeutics Inc14.14-395.99%
NAGENiagen Bioscience Inc14.82-410.27%
INCYIncyte Corp15.82-431.30%
REGNRegeneron Pharmaceuticals Inc15.86-432.01%
PBYIPuma Biotechnology Inc17.32-462.56%
CPRXCatalyst Pharmaceuticals Inc17.44-465.15%
EXELExelixis Inc17.54-467.22%
TGTXTG Therapeutics Inc18.97-497.12%
MDXGMimedx Group Inc20.55-530.33%
XOMAXOMA Royalty Corp22.87-578.97%
ARGXArgen X SE24.30-608.77%
CTMXCytomX Therapeutics Inc24.82-619.72%
XOMAOXOMA Royalty Corp25.34-630.69%
HALOHalozyme Therapeutics Inc25.62-636.53%
XOMAPXOMA Royalty Corp25.67-637.50%
VRTXVertex Pharmaceuticals Inc27.99-686.18%
RPRXRoyalty Pharma plc - Class A28.69-700.68%
SLNOSoleno Therapeutics Inc29.02-707.55%
ASNDAscendis Pharma A/S30.09-729.96%
LGNDLigand Pharmaceuticals Inc - Class B37.91-893.83%
APLSApellis Pharmaceuticals Inc39.02-917.06%
BMRNBiomarin Pharmaceutical Inc42.21-983.87%
KRYSKrystal Biotech Inc45.34-1049.44%
ONCBeiGene Ltd69.54-1556.09%
PHARPharming Group N.V.75.03-1670.95%
TECHBio-Techne Corp101.96-2234.89%
VCELVericel Corp109.92-2401.62%
ALNYAlnylam Pharmaceuticals Inc117.96-2570.05%
GMABGenmab140.29-3037.52%
TLXTelix Pharmaceuticals Ltd162.15-3495.29%
CORTCorcept Therapeutics Inc212.86-4556.98%